Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 2, 2010, Pages 104-108

  Eshun Wilson, Ingrid ^a   Havers, Fiona ^b   Nachega, Jean B ^c,d   Prozesky, Hans W ^a   Taljaard, Jantjie J ^a   Zeier, Michele D ^a   Cotton, Mark ^a   Simon, Gary ^e   Soentjens, Patrick ^f,g  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

HIV; Immune reconstitution; INSHI; Resource limited settings; Tuberculosis

Indexed keywords

CORTICOSTEROID; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ADULT; ARTICLE; ENDEMIC DISEASE; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MALE; PARADOXICAL TUBERCULOSIS ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PREVALENCE; PRIORITY JOURNAL; SOUTH AFRICA; STANDARDIZATION; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MYCOBACTERIUM TUBERCULOSIS; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS;

EID: 77953681426     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710361537     Document Type: Article

References (16)

1. Lawn SD, Landon M, Bekker L, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20(12):1605-1612.
2. Deana GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16(1):75-83.
3. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an anti-retroviral treatment service in South Africa. AIDS. 2007;21(3):335-341.
4. Kumarasamy N, Chaguturu A, Mayer KH, et al. Incidence of Immune Reconstitution Syndrome in HIV/Tuberculosis-Coinfected Patients After Initiation ofGeneric Antiretroviral Therapy in India. Acquir Immune Defic Syndr. 2004;37(5):1574-1576.
5. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect. 2006;53(6):357-363.
6. Breton G, Duval X, Estellat C, et al. Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1-infected Patients with Tuberculosis after Initiation of Antiretroviral Therapy. Clin Infec Dis. 2004;39(11):1709-1712.
7. Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther. 2005;10(3):417-422.
8. Burman W, Weis S, Vernon A, et al. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis. 2007;11(12):1282-1289.
9. Breen RA, Smith CJ, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59(8):704-707.
10. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399-406.
11. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158(1): 157-161.
12. Pepper DJ, Marais S, Maartens G, et al. Neurological manifestations of paradoxical tuberculsosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infec Dis. 2009;48(11):e96-e107.
13. Meintjies G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008; 8(8):516-523.
14. World Health Organization. Tuberculosis. Definitions of Tuberculosis Cases and treatment outcomes. WHO Report 2007. http://www.who.int/tb/ publications/global-report/2007/table-5/en/ Accessed March 15, 2009.
15. Meintjies G, Rangaka MX, Maartens G, et al. Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance antitubercular drug resistance. Clin Infect Dis. 2009;48(5):667-676.
16. Meintjies G, Wilkinson R, Morroni C, et al. Randomized Placebo-controlled Trial of Prednisone for the TB Immune Reconstitution Inflammatory Syndrome [Abstract 34]. Presented at: Conference on Retroviruses and Opportunistic Infections, 2009; Montreal.